Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multiple-Dose Study of Intravenous BNZ132-1-40 in Healthy Adult Subjects

NCT03239379 is registered in ClinicalTrials.gov with Bioniz Therapeutics as lead sponsor.

NCT NCT03239379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03239379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multiple-Dose Study of Intravenous BNZ132-1-40 in Healthy Adult Subjects
Lead sponsor
Bioniz Therapeutics
Phase
Phase 1
Overall status
Completed
Start date
October 30, 2017
Completion date
March 8, 2018
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

safety and tolerability in healthy subjects